CL2007002505A1 - USE OF A BIFEPRUNOX COMPOUND FOR THE TREATMENT OF AT LEAST ONE CONDITION OF THE CENTRAL NERVOUS SYSTEM; AND DEGREE KIT THAT UNDERSTANDS UNIT DOSE. - Google Patents

USE OF A BIFEPRUNOX COMPOUND FOR THE TREATMENT OF AT LEAST ONE CONDITION OF THE CENTRAL NERVOUS SYSTEM; AND DEGREE KIT THAT UNDERSTANDS UNIT DOSE.

Info

Publication number
CL2007002505A1
CL2007002505A1 CL2007002505A CL2007002505A CL2007002505A1 CL 2007002505 A1 CL2007002505 A1 CL 2007002505A1 CL 2007002505 A CL2007002505 A CL 2007002505A CL 2007002505 A CL2007002505 A CL 2007002505A CL 2007002505 A1 CL2007002505 A1 CL 2007002505A1
Authority
CL
Chile
Prior art keywords
kit
degree
treatment
condition
nervous system
Prior art date
Application number
CL2007002505A
Other languages
Spanish (es)
Inventor
Luigi M Van Den Broeck Barbato
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40261481&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007002505(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of CL2007002505A1 publication Critical patent/CL2007002505A1/en

Links

CL2007002505A 2006-08-31 2007-08-28 USE OF A BIFEPRUNOX COMPOUND FOR THE TREATMENT OF AT LEAST ONE CONDITION OF THE CENTRAL NERVOUS SYSTEM; AND DEGREE KIT THAT UNDERSTANDS UNIT DOSE. CL2007002505A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84124406P 2006-08-31 2006-08-31
EP06119936 2006-08-31
EP06120016 2006-09-01

Publications (1)

Publication Number Publication Date
CL2007002505A1 true CL2007002505A1 (en) 2008-04-04

Family

ID=40261481

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2007002505A CL2007002505A1 (en) 2006-08-31 2007-08-28 USE OF A BIFEPRUNOX COMPOUND FOR THE TREATMENT OF AT LEAST ONE CONDITION OF THE CENTRAL NERVOUS SYSTEM; AND DEGREE KIT THAT UNDERSTANDS UNIT DOSE.

Country Status (2)

Country Link
CL (1) CL2007002505A1 (en)
RU (1) RU2009111604A (en)

Also Published As

Publication number Publication date
RU2009111604A (en) 2010-10-10

Similar Documents

Publication Publication Date Title
CL2008000224A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES A GLUCOPIRANOSIL DERIVATIVE COMPOUND; AND USE FOR THE TREATMENT OF ONE OR MORE NEURODEGENERATIVE DISORDERS.
CL2007003520A1 (en) COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE PI3 QUINASA ACTIVITY; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE FOR CANCER PROFILACTIC OR THERAPEUTIC TREATMENT.
CL2008000691A1 (en) COMPOUNDS DERIVED FROM DIHIDRO AND TETRAHIDRO OXAZOLOPIRIMIDINONAS REPLACED; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF CHICHOPHRENIA, EPILEPSY, BETWEEN OTHER DISEASES.
CL2007003352A1 (en) COMPOUNDS DERIVED FROM NITROGEN HETEROMONOCYCLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CIRCULATORY DISEASES, METABOLIC DISEASES AND / OR DISEASES OF THE CEN NERVOUS SYSTEM
CL2007002641A1 (en) COMPOUNDS DERIVED FROM PYRIMIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF ALLERGIC DISORDERS, AUTOIMMUNES, INFLAMMATORY DISEASES.
CL2007003138A1 (en) COMPOUNDS DERIVED FROM ANILINOPIPERAZINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
CL2007002234A1 (en) COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2007002974A1 (en) COMPOUNDS DERIVED FROM BENZOIMIDAZOL; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH DGAT1.
CL2007003244A1 (en) COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] [2] BENZAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
CL2007003686A1 (en) COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION.
CL2007003202A1 (en) COMPOUNDS DERIVED FROM ESPIROINDOLINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS.
CL2008000377A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED FUSED CYCLES; PHARMACEUTICAL AGENT UNDERSTANDING THESE COMPOUNDS; AND USE FOR THE PREVENTION OR TREATMENT OF DIABETES.
CL2007002594A1 (en) COMPOUNDS DERIVED FROM PIRIDIN-3-IL, IMMUNOMODULATING AGENTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN ACTIVATED IMMUNOLOGICAL SYSTEM. .
CL2012003281A1 (en) Use of specific sgc stimulating and / or activating compounds; pharmaceutical formulation comprising said compounds; kit comprising the compounds, and use for the prevention and / or treatment of systematic sclerosis.
CL2011003350A1 (en) Nitrogenous heterocycle derivative compounds, pkm2 modulators; pharmaceutical composition comprising them; and its use in the treatment of cancer.
CL2008002295A1 (en) Alkylsulfonyl-substituted thiazolid derivative compounds; pharmaceutical composition; and use for the treatment of hepatitis c.
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
CL2007002479A1 (en) COMPOUNDS DERIVED FROM PIRAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS.
CL2008002049A1 (en) Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c.
CL2007002920A1 (en) COMPOUNDS DERIVED FROM 2-AMINOCARBONYLPIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
CL2007001630A1 (en) COMPOUNDS DERIVED FROM PIRROLIDINAMIDE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF HEPATITIS C.
BRPI0912539A2 (en) compound, pharmaceutical composition, method for treating a disease, and use of the compound.
CL2007003232A1 (en) COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.
CL2008000641A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED AMIDAS; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF INSOMNIUM, SEXUAL DYSFUNCTION, SCHIZOPHRENIA, BETWEEN OTHER SICK